Miramar Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.5M Sell
55,719
-1,670
-3% -$496K 3.66% 9
2025
Q4
$15.7M Sell
57,389
-124
-0.2% -$33.7K 3.42% 11
2025
Q3
$15.5M Sell
57,513
-149
-0.3% -$40.5K 3.45% 12
2025
Q2
$15.9M Buy
57,662
+293
+0.5% +$79.7K 3.76% 7
2025
Q1
$15.2M Sell
57,369
-1,774
-3% -$438K 3.62% 8
2024
Q4
$13.7M Buy
59,143
+247
+0.4% +$56.8K 3.28% 12
2024
Q3
$13M Sell
58,896
-82
-0.1% -$17K 3.03% 14
2024
Q2
$11.6M Buy
58,978
+272
+0.5% +$56.2K 2.9% 19
2024
Q1
$12.2M Buy
58,706
+8,804
+18% +$1.85M 3.09% 16
2023
Q4
$10.5M Buy
49,902
+13,629
+38% +$2.91M 2.74% 21
2023
Q3
$7.26M Buy
+36,273
New +$7.21M 1.97% 27

Other funds holding CME

Miramar Capital's CME Position: Q1 2026 in Review

Miramar Capital reduced its CME Group (CME) stake by 2.9% in Q1 2026, selling an estimated $496K and leaving 55,719 shares worth $16.5M. The position accounts for 3.66% of the portfolio, ranked #9.

Miramar Capital first reported a position in CME in Q3 2023 and has held it in 11 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Miramar Capital held 55,719 shares of CME Group worth $16.5M as of Q1 2026.
  • Miramar Capital sold 1,670 CME Group shares in Q1 2026, an estimated $496K.
  • CME Group made up 3.66% of Miramar Capital's portfolio in Q1 2026, its #9 holding.
  • Miramar Capital first reported a position in CME Group in Q3 2023 and has held it in 11 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Miramar Capital's 13F filing for Q1 2026, filed 11 May 2026.